Qube Research & Technologies (QRT)
KYTX icon

Qube Research & Technologies (QRT)’s Kyverna Therapeutics KYTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Sell
123,646
-210,046
-63% -$1.86M ﹤0.01% 2376
2026
Q1 		$2.88M Buy
333,692
+270,076
+425% +$2.25M ﹤0.01% 1957
2025
Q4 		$598K Buy
63,616
+26,925
+73% +$200K ﹤0.01% 2748
2025
Q3 		$220K Buy
36,691
+22,640
+161% +$90.5K ﹤0.01% 2924
2025
Q2 		$43.1K Buy
+14,051
New +$34.8K ﹤0.01% 3178
2024
Q3 		– Sell
-42,424
Closed -$318K – 4256
2024
Q2 		$318K Sell
42,424
-26,813
-39% -$410K ﹤0.01% 2288
2024
Q1 		$1.72M Buy
+69,237
New +$1.93M ﹤0.01% 1844

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KYTX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Kyverna Therapeutics (KYTX) stake by 63% in Q2 2026, selling an estimated $1.86M and leaving 123,646 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Qube Research & Technologies (QRT) first reported a position in KYTX in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.88M in Q1 2026. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 123,646 shares of Kyverna Therapeutics worth $1.1M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 210,046 Kyverna Therapeutics shares in Q2 2026, an estimated $1.86M.
  • Kyverna Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2376 holding.
  • Qube Research & Technologies (QRT) first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Kyverna Therapeutics position peaked at $2.88M in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.